Daxor corporation announces closing of $4.0 million underwritten public offering

Oak ridge, tn, may 25, 2023 (globe newswire) -- daxor corporation (nasdaq: dxr) (“daxor”, or the “company”), the global leader in blood volume measurement technology, today announced the closing of its previously announced underwritten public offering of 410,260 shares of its common stock at a public offering price of $9.75 per share. gross proceeds from the offering are approximately $4.0 million before deducting underwriting discounts, commissions, and estimated offering expenses.
DXR Ratings Summary
DXR Quant Ranking